Cargando…

Deferasirox treatment of iron-overloaded chelation-naïve and prechelated patients with myelodysplastic syndromes in medical practice: results from the observational studies eXtend and eXjange

EXtend and eXjange were prospective, 1-yr, non-interventional, observational, multicentre studies that investigated deferasirox, a once-daily oral iron chelator, in iron-overloaded chelation-naïve and prechelated patients with myelodysplastic syndromes (MDS), respectively, treated in the daily-routi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gattermann, Norbert, Jarisch, Andrea, Schlag, Rudolf, Blumenstengel, Klaus, Goebeler, Mariele, Groschek, Matthias, Losem, Christoph, Procaccianti, Maria, Junkes, Alexia, Leismann, Oliver, Germing, Ulrich
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2012
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505370/ https://www.ncbi.nlm.nih.gov/pubmed/22023452 http://dx.doi.org/10.1111/j.1600-0609.2011.01726.x

Ejemplares similares

International Conference eXtended Discretization MethodS
por: Ventura, Giulio, et al.
Publicado: (2016)

XTMS: pathway design in an eXTended metabolic space
por: Carbonell, Pablo, et al.
Publicado: (2014)

Integrating and extending cohort studies: lessons from the eXtending Treatments, Education and Networks in Depression (xTEND) study
por: Allen, Joanne, et al.
Publicado: (2013)

Implementing domain-specific languages with Xtext and Xtend
por: Bettini, Lorenzo
Publicado: (2013)

Fragmentation functions using e+e- data from PETRA and LEP
por: Blumenstengel, Mona, et al.
Publicado: (2002)

Framework for Armature-Based 3D Shape Reconstruction of Sensorized Soft Robots in eXtended Reality
por: Borges, Elvis I. A., et al.
Publicado: (2022)

Full thermo-mechanical coupling using eXtended finite element method in quasi-transient crack propagation
por: Habib, Fakhreddine, et al.
Publicado: (2018)

Implementing domain-specific languages with Xtext and Xtend: learn how to implement a DSL with Xtext and Xtend using easy-to-understand examples and best practices
por: Bettini, Lorenzo
Publicado: (2016)

A framework for correcting brain retraction based on an eXtended Finite Element Method using a laser range scanner
por: Li, Ping, et al.
Publicado: (2013)

XTEND: Extending the depth of field in cryo soft X-ray tomography
por: Otón, Joaquín, et al.
Publicado: (2017)

Pharmacogenetic Study of Deferasirox, an Iron Chelating Agent
por: Lee, Ji Won, et al.
Publicado: (2013)

Comparative modelling of crack propagation in elastic–plastic materials using the meshfree local radial basis point interpolation method and eXtended finite-element method
por: Li, Yazhe, et al.
Publicado: (2019)

Effects of an oral iron chelator, deferasirox, on advanced hepatocellular carcinoma
por: Saeki, Issei, et al.
Publicado: (2016)

From Biology to Clinical Practice: Iron Chelation Therapy With Deferasirox
por: Palumbo, Giuseppe A., et al.
Publicado: (2021)

Hypersensitivity reaction with deferasirox
por: Sharma, Atul, et al.
Publicado: (2015)

Effects of oral iron chelator deferasirox on human malignant lymphoma cells
por: Choi, Jong Gwon, et al.
Publicado: (2012)

Iron Chelation Therapy with Deferasirox in the Management of Iron Overload in Primary Myelofibrosis
por: Elli, Elena Maria, et al.
Publicado: (2014)

Deferasirox, an oral iron chelator, prevents hepatocarcinogenesis and adverse effects of sorafenib
por: Yamamoto, Naoki, et al.
Publicado: (2016)

Chelation of Thallium (III) in Rats Using Combined Deferasirox and Deferiprone Therapy
por: Salehi, Samie, et al.
Publicado: (2017)

Missed Opportunities for TB Investigation in Primary Care Clinics in South Africa: Experience from the XTEND Trial
por: Chihota, Violet N., et al.
Publicado: (2015)

Computer Vision Meets Image Processing and UAS PhotoGrammetric Data Integration: From HBIM to the eXtended Reality Project of Arco della Pace in Milan and Its Decorative Complexity
por: Banfi, Fabrizio, et al.
Publicado: (2021)

Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox
por: Amano, Shogo, et al.
Publicado: (2020)

Assessing the Prognosis of Patients with Myelodysplastic Syndromes (MDS)
por: Kasprzak, Annika, et al.
Publicado: (2022)

Deferasirox: Duodenal perforation: case report
Publicado: (2021)

Comparison of the effects of deferasirox, deferoxamine, and combination of deferasirox and deferoxamine on an aplastic anemia mouse model complicated with iron overload
por: Wu, Dijiong, et al.
Publicado: (2018)

Use of deferasirox, an iron chelator, to overcome imatinib resistance of chronic myeloid leukemia cells
por: Kim, Dae Sik, et al.
Publicado: (2016)

Iron Chelation Therapy With Deferasirox in Sickle Cell Disease With End-Stage Renal Disease
por: Raj, Ashok, et al.
Publicado: (2022)

Correction: Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox
por: Amano, Shogo, et al.
Publicado: (2023)

Extension of Tablo TrEatmeNt Duration (XTEND) study: successful 24 h prolonged therapy with Tablo in critical patients
por: Zaman, Tahir, et al.
Publicado: (2022)

Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation
por: Finkenstedt, Armin, et al.
Publicado: (2010)

Low oxygen tension reverses antineoplastic effect of iron chelator deferasirox in human glioblastoma cells
por: Legendre, Claire, et al.
Publicado: (2016)

Single-center retrospective study of the effectiveness and toxicity of the oral iron chelating drugs deferiprone and deferasirox
por: Olivieri, Nancy F., et al.
Publicado: (2019)

Update on the use of deferasirox in the management of iron overload
por: Taher, Ali, et al.
Publicado: (2009)

Deferasirox: Over a Decade of Experience in Thalassemia
por: Moukalled, Nour M., et al.
Publicado: (2018)

Deferasirox – a rarer cause of Fanconi syndrome
por: Khan, Iman, et al.
Publicado: (2019)

Synthesis and Study of Multifunctional Cyclodextrin–Deferasirox Hybrids
por: Gascon, Jose Miguel, et al.
Publicado: (2019)

Evaluation of Pharmacokinetics and Pharmacodynamics of Deferasirox in Pediatric Patients
por: Galeotti, Laura, et al.
Publicado: (2021)

Normal pregnancy in a patient with β-thalassaemia major receiving iron chelation therapy with deferasirox (Exjade®)
por: Vini, Dimitra, et al.
Publicado: (2011)

Deferasirox, an oral iron chelator, with gemcitabine synergistically inhibits pancreatic cancer cell growth in vitro and in vivo
por: Shinoda, Shuhei, et al.
Publicado: (2018)

Correction: Single-center retrospective study of the effectiveness and toxicity of the oral iron chelating drugs deferiprone and deferasirox
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_d3g1dbpec4dtfnm3qr1kaa1bn2